PCSK9 inhibitor chemical & modality series
PCSK9 / LDL-CNot analyzedPCSK9 inhibitor chemical & modality series. Independently sourced molecular structures from PubChem. Family membership is an editorial grouping, not evidence of a shared scaffold, synthesis route, or clinical performance.
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.
How similarity is calculated · How clustering works · How exploration priority is scored
Spider Web · Flow · Structure table · Compare · SMILES map
The actual comparison question for this family
We compared 1 distinct molecular pairs across 2 independent CIDs. Which pairs share more encoded local atom environments within this grouping, and which share fewer?
Largest fingerprint overlap in this family: 0.302
Enlicitide ↔ MK-0616 · Morgan r=2 / 2048 bits / Tanimoto
The graph displays 1 relationships, which can differ from the complete 1 pair comparisons. The public graph shows scores of at least 0.2 for readability; no edge does not imply no biological activity.
The range and extrema apply only to the current catalog members. They do not establish development success, an identical scaffold or clinical superiority.
Calculation check: 2026-10-16 · RDKit
Loading map…
임상 자료는 별도 근거로 확인합니다 / Clinical evidence
구조 출처 확인은 승인·효능 검증과 다릅니다. 아래 링크는 원문 검색 경로이며 승인 상태나 결과를 보증하지 않습니다.
ClinicalTrials.gov · 원문 검색